Cuban researchers tested the HIV / AIDS vaccine

On February 24, a group of Cuban researchers said it had developed a therapeutic vaccine for patients with immunodeficiency syndrome (HIV / AIDS) , currently in testing. Clinical and expected to be a new option besides current antiretrovirals (ARVs) .

According to researcher Yayri Caridad Prieto, of La Habana Center for Genetics and Biotechnology (CIGB), this vaccine called TERAVAC-VIH has been tested on 9 patients and does not show harmful or toxic effects. .

The application of TERAVAC-VIH is carried out in parallel with 2 lines, which are injected between the muscles and nasal spray.

Speaking at an international medical conference taking place in La Habana, Ms. Pietro stressed that the vaccine has no cure for AIDS, but aims to replace the current common three-part therapy model.

Cuban scientist said that the current common measure inhibits the development of HIV highly effective, but causes many side effects that in many cases force patients to stop treatment for a while.

The application of TERAVAC-VIH is carried out in parallel with 2 lines, which are injected between the muscles and nasal spray. So far, preclinical studies on laboratory animals and trials on a small group of voluntary patients have demonstrated the ability of this new drug to enhance the organism's immunity. viscera and reduced viral load in CD8 cells . However, Ms. Prieto also warned that this project will also take at least several years of research at higher experimental stages and with more patients.

According to official statistics, since the discovery of the first patient carrying the HIV virus in 1985 until November 2016, Cuba has diagnosed more than 26,000 people carrying this virus of " twentieth-century disease" .